RxDoctor Payments DataLook up a doctor →

Isam Marar, MD

Internal Medicine · Council Bluffs, IANPI 1104976109

Payments from drug & device makers

$1,478,423in general payments, 2019–2025

Across 2,022 payments — averaging $731.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$665K
  • Novartis$298K
  • Kowa Research Institute, Inc.$203K
  • Novo Nordisk AS$160K
  • Ionis Pharmaceuticals, Inc.$60K
  • Pfizer$26K
  • plus $67K from 54 others
$1,548in research payments, 2019–2025

Across 14 payments — averaging $110.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)232$664,926
Novartis42$297,995
Kowa Research Institute, Inc.46$202,943
Novo Nordisk AS454$160,160
Ionis Pharmaceuticals, Inc.6$59,781
Pfizer66$25,824
Esperion Therapeutics, Inc.59$21,721
Gilead66$17,278
Janssen Research & Development, LLC2$9,504
Lilly USA, LLC163$2,233
Amgen126$2,197
AstraZeneca80$2,026
Novo Nordisk116$1,920
Astellas Pharma US Inc36$970
Johnson & Johnson54$871
Bayer40$819
Merck45$691
GSK57$623
Amarin Pharma, Inc.31$578
Sanofi-aventis U.S. LLC32$522
Boehringer Ingelheim25$361
Aimmune Therapeutics, Inc.5$348
Medtronic(2 entities)6$283
Mannkind Corporation14$280
Takeda Pharmaceuticals U.S.A., Inc.18$259
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$234
E.r. Squibb & Sons, L.L.C.15$220
Abbott10$209
Otsuka America Pharmaceutical, Inc.9$190
Xeris Pharmaceuticals, Inc.10$155
Sumitomo Pharma America, Inc.8$145
Biohaven Pharmaceutical Holding Company Ltd.9$142
Mylan Specialty L.p.9$142
Kowa Pharmaceuticals America, Inc.11$142
Radius Health, Inc.7$120
Biohaven Pharmaceuticals, Inc.7$116
Sunovion Pharmaceuticals Inc.9$112
Corcept Therapeutics6$108
Boston Scientific4$100
Eisai Inc.5$98
Idorsia Pharmaceuticals US Inc5$86
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$69
Jazz Pharmaceuticals Inc.3$56
Nalpropion Pharmaceuticals LLC4$55
Lundbeck LLC3$54
Biogen3$54
Verona Pharma, Inc.3$48
Regeneron Healthcare Solutions, Inc.3$48
Axsome Therapeutics, Inc.3$46
Ironwood Pharmaceuticals, Inc2$36
Ascensia Diabetes Care US Inc.2$35
Nestle Healthcare Nutrition Inc.2$34
Azurity Pharmaceuticals, Inc.2$34
Seqirus USA Inc2$34
Amryt Pharma Holdings Ltd2$34
Ardelyx, Inc.2$30
Ipsen Biopharmaceuticals, Inc1$24
Vertex1$19
Lifescan, Inc.1$18
VBI Vaccine (delaware) Inc.1$17

How this compares

$1,478,423 in reported general payments places this provider in the 95th percentile of 583 internal medicine providers in Iowa.

See all internal medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$179,467
Medicare patients
299
Services billed
3,679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Council Bluffs

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →